ADMA Biologics, Inc.

( )
ADMA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
REGNRegeneron Pharmaceuticals, Inc. -0.55%582.522.7%$671.55m
AMGNAmgen, Inc. -0.64%223.461.3%$579.11m
GILDGilead Sciences, Inc. 0.08%60.011.0%$578.78m
VRTXVertex Pharmaceuticals, Inc. 2.43%212.191.9%$533.31m
MRNAModerna, Inc. 0.61%70.670.0%$451.00m
ILMNIllumina, Inc. 0.84%321.743.5%$422.57m
EXASEXACT Sciences Corp. 23.04%131.1220.7%$294.14m
NVAXNovavax, Inc. 2.53%89.5996.5%$273.94m
ALXNAlexion Pharmaceuticals, Inc. -0.63%120.002.0%$268.90m
BIIBBiogen, Inc. -0.57%255.301.7%$264.14m
BNTXBioNTech SE 1.23%83.950.0%$211.49m
SRNESorrento Therapeutics, Inc. -2.65%7.711.4%$151.30m
SGENSeagen Inc. 0.56%196.926.0%$150.43m
CRSPCRISPR Therapeutics AG 4.24%98.120.6%$126.32m
TXG10X Genomics, Inc. 1.20%142.930.0%$104.03m

Company Profile

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in the manufacturing, marketing and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.